Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2012
12/19/2012CN102827144A Preparation method of imatinib
12/19/2012CN102827143A Novel synthetic method for fluoroquinolone and salts thereof
12/19/2012CN102827142A Quinoline-8-formamide compound as well as preparation method and applications thereof
12/19/2012CN102827091A Triazine mercapto derivate as well as preparation method and application thereof
12/19/2012CN102827078A Condensed-cyclic compound and organic light-emitting diode comprising the same
12/19/2012CN102827073A Therapeutically active compositions and application methods thereof
12/19/2012CN102070612B Method for preparing hydroxyl fasudil compounds
12/19/2012CN101899036B Method for preparing sertindole by using alkyl imidazole type ionic liquid as solvent
12/19/2012CN101863879B Preparation method of alpha crystalline azelnidipine
12/19/2012CN101486706B Omeprazole sodium compound and method for synthesizing the same
12/19/2012CN101068794B Quinazolines useful as modulators of ion channels
12/18/2012US8334382 Substituted biaryl piperazinyl-pyridine analogues
12/18/2012US8334381 Process for the preparation of intermediates useful in the synthesis of imatinib
12/18/2012US8334317 Calcium receptor modulating agents
12/18/2012US8334313 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334292 Pyrimidine compounds and methods of making and using same
12/18/2012US8334291 Aliphatically substituted pyrazolopyridines, and the use thereof
12/18/2012US8334289 Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
12/18/2012US8334288 4-phenoxymethylpiperidines as modulators of GPR119 activity
12/18/2012US8334287 Imidazoles
12/18/2012US8334236 Ring-fused 2-pyridone derivatives and herbicides
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/18/2012CA2517517C P38 inhibitors and methods of use thereof
12/18/2012CA2504385C Thiadiazine compounds and uses thereof
12/15/2012CA2801835A1 Crystalline forms of thalidomide and processes for their preparation
12/13/2012WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012WO2012170867A1 Novel compounds as modulators of gpr-119
12/13/2012WO2012170752A1 Novel compounds
12/13/2012WO2012170702A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
12/13/2012WO2012170561A1 N-benzylindole modulators of pparg
12/13/2012WO2012170554A1 N-biphenylmethylindole modulators of pparg
12/13/2012WO2012170098A2 Arbovirus inhibitors and uses thereof
12/13/2012WO2012170035A1 Surfactants with a terminal dialkyl- or cycloalkyl-substituted tertiary amine and inks including the same
12/13/2012WO2012169821A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
12/13/2012WO2012169733A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
12/13/2012WO2012169649A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/13/2012WO2012169555A1 Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound
12/13/2012WO2012168710A1 Hydantoin derivates as kv3 inhibitors
12/13/2012WO2012168359A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/13/2012WO2012168350A1 Pyridin- 2 -amides useful as cb2 agonists
12/13/2012WO2012168349A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/13/2012WO2012168315A1 Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
12/13/2012WO2012168265A1 Substituted benzamide derivatives
12/13/2012WO2012168226A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012WO2012167600A1 A heterocyclic [b]pyridone compound, intermediates thereof, method of preparation and uses
12/13/2012WO2011156554A8 Cyclohexyl-azetidinyl antagonists of ccr2
12/13/2012US20120316344 Benzimidazole compound crystal
12/13/2012US20120316338 Methods and Intermediates for the Preparation of Optionally Radio-Labeled Imatinib
12/13/2012US20120316203 Compositions and Methods for Inhibition of Cancers
12/13/2012US20120316202 Compounds which have activity at M1 receptor and their uses in medicine
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316200 Pyridone derivatives
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316185 Cyclohexyl Amide Derivatives as CRF Receptor Antagonists
12/13/2012US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316170 Imidazole Derivative
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316167 Secondary 8-hydroxyquinoline-7-carboxamide derivatives
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316151 Triazolones as fatty acid synthase inhibitors
12/13/2012US20120316150 Amide compounds useful in therapy
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120315302 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120315247 Compounds comprising a spiro-ring and methods of use
12/13/2012US20120315217 Inverse agonists and neutral antagonists for the tsh receptor
12/13/2012US20120313041 Four-ring compound having a plurality of cf2o bonding groups, liquid crystal composition and liquid crystal display device
12/13/2012CA2838777A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/13/2012CA2838435A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012CA2837703A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
12/13/2012CA2836487A1 Novel compounds as modulators of gpr-119
12/13/2012CA2835745A1 Pyridin - 2 - amides useful as cb2 agonists
12/13/2012CA2834675A1 Substituted benzamide derivatives
12/13/2012CA2833771A1 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012CA2833507A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/12/2012EP2532659A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
12/12/2012EP2532658A1 Therapeutic agent for cerebral infarction
12/12/2012EP2532657A2 Compounds and methods of use
12/12/2012EP2532656A1 Gpr119 agonist
12/12/2012EP2532653A1 Benzo[1,2,4]triazines as protein kinase modulators
12/12/2012EP2532650A2 Modulators of ATP-binding cassette transporters
12/12/2012EP2531498A1 Compounds and compositions as protein kinase inhibitors
12/12/2012EP2531492A1 1,2,4-triazine-4-amine derivatives
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
12/12/2012EP2531487A1 Aryl benzylamine compounds
12/12/2012CN102822169A Substituted naphthalenyl-pyrimidine compounds
12/12/2012CN102822165A Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/12/2012CN102822164A Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salt
12/12/2012CN102822163A Crth2 modulators
12/12/2012CN102822150A 1,2,4-triazine-4-amine derivatives
12/12/2012CN102822148A Therapeutic agent or prophylactic agent for fibromyalgia
12/12/2012CN102816149A Preparation method for high-enantioselectivity synthesized (S)-omeprazole and salt thereof
12/12/2012CN102816148A Fungicidal azocyclic amides
12/12/2012CN102816147A Flumatinib mesylate crystal form B and preparation method and use thereof
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 1080